hyoscyamine has been researched along with gemifloxacin in 1 studies
| Studies (hyoscyamine) | Trials (hyoscyamine) | Recent Studies (post-2010) (hyoscyamine) | Studies (gemifloxacin) | Trials (gemifloxacin) | Recent Studies (post-2010) (gemifloxacin) |
|---|---|---|---|---|---|
| 99 | 1 | 55 | 320 | 46 | 80 |
| Protein | Taxonomy | hyoscyamine (IC50) | gemifloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Staphylococcus aureus | 5.6 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 0.5 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 0.5 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.3 | |
| DNA gyrase subunit A | Staphylococcus aureus | 5.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for hyoscyamine and gemifloxacin
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |